BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 32475726)

  • 1. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
    Gao FF; Austin RM; Zhao C
    Cancer Cytopathol; 2011 Dec; 119(6):377-86. PubMed ID: 21774093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
    Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
    Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
    Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
    Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
    PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
    Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
    J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
    Narkcham S; Mody DR; Jones A; Thrall MJ
    J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.
    Rao R; Molina D; Halligan AM; Vakil B; Alperstein SA; Hoda RS
    Diagn Cytopathol; 2015 Sep; 43(9):763-9. PubMed ID: 26173579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
    Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
    Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Agoff SN; Brockmeyer AD; Barrie AM; Larson J
    Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.